KOREA CENTER FOR DISEASE CONTROL AND PREVENTION;대한민국(관리부서 질병관리본부장)
发明人:
LEE, JUNG AHKR,이정아,IN, HYUN JUKR,인현주,LIM, HEE JIKR,임희지,HYEON, JI YEONKR,현지연,YEO, SANG GUKR,여상구,JEONG, HYE SOOKKR,정혜숙,LEE, JUNE WOOKR,이준우,YOO, JUNG SIKKR,유정식,LEE, SANG WONKR,이상원,LEE, JUNG AH,IN, HYUN JU,LIM, HEE JI,HYEON, JI YEON,YEO, SANG GU,JEONG, HYE SOOK,LEE, JUNE WOO,YOO, JUNG SIK,LEE, SANG WON
申请号：
KR1020170026363
公开号：
KR1020180099226A
申请日:
2017.02.28
申请国别(地区):
KR
年份:
2018
代理人:
摘要：
The present invention relates to a novel enterovirus (EV) type 71 strain, and an inactivated vaccine composition for preventing foot and mouth diseases using the same. According to the present invention, an inactivated EV71 vaccine candidate is highly effective in vaccination such as neutralizing antibody activities, protective abilities, and passive immune functions. Thus, the vaccine composition of the present invention can be used as an effective vaccine for preventing foot and mouth diseases.COPYRIGHT KIPO 2018본 발명은 신규한 엔테로바이러스 71형 균주 및 이를 이용한 수족구병 예방용 불활화 백신 조성물에 관한 것이다. 본 발명에 따른 EV71형 불활화 백신 후보주는 중화항체능, 방어능 및 수동면역반응효과 등의 백신 효과가 우수한 것으로 확인되었으므로, 본 발명의 백신 조성물은 효과적인 수족구병 예방용 백신으로 사용될 수 있다.
